PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Pharmacology, Gilead Sciences, Foster City, CA, USA; Department of Chemistry, University of California, Riverside, CA, USA.\', \'Department of Clinical Pharmacology, Gilead Sciences, Foster City, CA, USA. Electronic address: deqing.xiao@gilead.com.\', \'Department of Clinical Pharmacology, Gilead Sciences, Foster City, CA, USA.\', \'KCAS Bioanalytical & Biomarker Services, Shawnee, KS, USA.\', \'Department of Chemistry, University of California, Riverside, CA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0731-7085(22)00067-X10.1016/j.jpba.2022.114646
?:hasPublicationType
?:journal
  • Journal of pharmaceutical and biomedical analysis
is ?:pmid of
?:pmid
?:pmid
  • 35180564
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.919
?:rankingScore_hIndex
  • 108
is ?:relation_isRelatedTo_publication of
?:title
  • The determination of Sulfobutylether β-Cyclodextrin Sodium (SBECD) by LC-MS/MS and its application in remdesivir pharmacokinetics study for pediatric patients.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35180564>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35180564>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all